Indication
Treatment of adult patients with advanced hormone-sensitive prostate cancer.
Medicine details
- Medicine name:
- relugolix (Orgovyx)
- SMC ID:
- SMC2678
- Pharmaceutical company
- Accord Healthcare
- BNF chapter
- Malignant disease and immunosuppression
- Submission type
- Full
- Publication due date:
- TBC
- SMC meeting date:
- TBC
- Patient group submission deadline:
- 06 August 2024